Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies

被引:213
|
作者
Wang, Tao [1 ]
Upponi, Jaydev R. [1 ]
Torchilin, Vladimir P. [1 ]
机构
[1] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA
关键词
Multifunctional non-viral gene vectors; Delivery barriers; Long-circulation; Targeted delivery; Cytoplamic delivery; Nuclear import; PLASMID-LIPID PARTICLES; ARGININE-RICH PEPTIDES; NUCLEAR-LOCALIZATION SIGNALS; SMALL INTERFERING RNA; TRANSFER IN-VITRO; NANO DEVICE MEND; INTRACELLULAR TRAFFICKING; DELIVERY-SYSTEM; ANTISENSE OLIGONUCLEOTIDES; EXTENDED CIRCULATION;
D O I
10.1016/j.ijpharm.2011.07.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene-based therapeutics hold great promise for medical advancement and have been used to treat various human diseases with mixed success. However, their therapeutic application in vivo is limited due largely to several physiological barriers. The design of non-viral gene vectors with the ability to overcome delivery obstacles is currently under extensive investigation. These efforts have placed an emphasis on the development of multifunctional vectors able to execute multiple tasks to simultaneously overcome both extracellular and intracellular obstacles. However, the assembly of these different functionalities into a single system to create multifunctional gene vectors faces many conflicts that largely limit the safe and efficient application of lipoplexes and polyplexes in a systemic delivery. In the review, we have described the dilemmas inherent in the design of a viable, non-viral gene vector equipped with multiple functionalities. The strategies directed towards individual delivery barriers are first summarized, followed by a focus on the design of so-called smart multifunctional vectors with the capability to overcome the delivery difficulties of gene medicines, including the so-called the "polycation dilemma", the "PEG dilemma" and the "package and release dilemma". (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 20
页数:18
相关论文
共 50 条
  • [41] Extracellular and intracellular barriers in non-viral gene delivery
    Ruponen, M
    Honkakoski, P
    Rönkkö, S
    Pelkonen, J
    Tammi, M
    Urtti, A
    JOURNAL OF CONTROLLED RELEASE, 2003, 93 (02) : 213 - 217
  • [42] Non-viral vectors in cancer gene therapy: principles and progress
    Schatzlein, AG
    ANTI-CANCER DRUGS, 2001, 12 (04) : 275 - 304
  • [43] Regulation of Endocytosis by Non-Viral Vectors for Efficient Gene Activity
    Islam, Mohammad Ariful
    Firdous, Jannatul
    Choi, Yun-Jaie
    Yun, Cheol-Heui
    Cho, Chong-Su
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (01) : 67 - 80
  • [44] Stimuli-responsive non-viral gene delivery vectors
    Ji Weihang
    Lin, Lin
    Chen Dayong
    Liu Wenguang
    PROGRESS IN CHEMISTRY, 2008, 20 (06) : 936 - 941
  • [45] Non-viral vectors for gene therapy and drug delivery - Preface
    Safinya, CR
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (02)
  • [46] Genocompatibility of non-viral vectors for gene-based therapies
    Akhtar, S
    Omidi, Y
    Hollins, A
    Drayton, R
    Benboubetra, M
    JOURNAL OF GENE MEDICINE, 2004, 6 (09): : S5 - S5
  • [47] Non-viral and hybrid vectors in human gene therapy: an update
    Schmidt-Wolf, GD
    Schmidt-Wolf, IGH
    TRENDS IN MOLECULAR MEDICINE, 2003, 9 (02) : 67 - 72
  • [48] Muscle gene transfer mediated by mesoangioblasts and non-viral vectors
    Iyer, Pavithra S.
    van Zwieten, Ruthger
    Ley, Deborah
    Mermod, Nicolas
    HUMAN GENE THERAPY, 2014, 25 (11) : A73 - A73
  • [49] Application of Non-Viral Vectors in Drug Delivery and Gene Therapy
    Ren, Shuaikai
    Wang, Mengjie
    Wang, Chunxin
    Wang, Yan
    Sun, Changjiao
    Zeng, Zhanghua
    Cui, Haixin
    Zhao, Xiang
    POLYMERS, 2021, 13 (19)
  • [50] Characterisation of non-viral gene delivery vectors for pulmonary administration
    Seville, PC
    Harris, NC
    Juggins, EC
    Young, JM
    Birchall, JC
    Kellaway, IW
    JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) : 288 - 291